Author

Andrew M. Nelson

Hackensack Meridian Health

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:deep learning· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Approach:machine learning (classical)· 1 Organism:mouse· 1

Frequent Co-Authors

Alberto Rojas-Triana· 1 shared Alexandra Bozan· 1 shared Amir George· 1 shared Camila Mendez Romero· 1 shared Camilla Folvar· 1 shared Connor W. ColeyiD· 1 shared David GraffiD· 1 shared David S. PerliniD· 1 shared

Activity by Year

2025-2025 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 20 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMicrobiology

Alberto Rojas-Triana

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Omicron Subvariants Infection Kinetics and Nirmatrelvir Efficacy in Transgenic K18-hACE2 Mice

Vijeta Sharma, Enriko Dolgov, Taylor Tillery, Camila Mendez Romero, Alberto Rojas-Triana, Diana Marcela Villalba Guzmán, Kira Goldgirsh, Risha Rasheed, Irene González-Jiménez, Nadine Álvarez, Steven Park, Madhuvika Murugan, Andrew M. Nelson, David S. Perlin

This study evaluates the infection kinetics and Nirmatrelvir efficacy against Omicron subvariants in transgenic mice, finding that these subvariants show distinct viral dynamics but remain susceptible to the antiviral.

International Journal of Molecular Sciences · Sep 29, 2025Peer-reviewedMicrobiology

Identification of Antituberculars with Favorable Potency and Pharmacokinetics through Structure-Based and Ligand-Based Modeling

Vedang Warapande, Fanwang Meng, Alexandra Bozan, David Graff, Jenna C. Fromer, Khadija Mughal, Faheem K. Mohideen, Shivangi Shivangi, Sindhuja Paruchuri, Melanie L. Johnston, Pankaj Sharma, Timothy R. Crea, Rudraraju Srilakshmi Reshma, Amir George, Camilla Folvar, , Joel S. Freundlich

The paper develops a hybrid modeling pipeline to identify antitubercular compounds with favorable potency and pharmacokinetics, resulting in 12 promising candidates from a large compound library.

bioRxiv · Feb 3, 2025 · PreprintMicrobiology